1117 Medical Laboratories
Welcome to the Laboratory of Ling-Zhi Liu, MD, PhD, at the University of Iowa Department of Pathology.
Left to Right: Long Jia, Ling-Zhi Liu, Nedria Walker and Khaliunaa Bayanbold
Dr. Liu is American Cancer Society Research Scholar. Her laboratory studies signaling pathways in tumorigenesis and cancer development at the molecular level. The laboratory is interested in both basic and translational studies. Projects include: 1) The role and mechanisms of signaling pathways in arsenic- and chromium- induced carcinogenesis; 2) Novel mechanisms of therapeutic resistance in ovarian cancer; 3) Mechanisms of acquired resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKIs) and radiation treatment in non-small cell lung cancer (NSCLC), and strategies to delay or recover the sensitivity of cancer cells to treatment; 4) The role of the tumor microenvironment in breast cancer development and treatment resistance. Dr. Liu’s laboratory is supported by R01 and K02 grant awards from NIH, and a Research Scholar Award from American Cancer Society. The laboratory is affiliated with the University of Iowa Holden Comprehensive Cancer Center Cancer Genes and Pathways (CGP) Program and the Cancer Biology Graduate Program.